Skip to Content

Workers’ Compensation Board

Search menu

OnBoard will be temporarily unavailable for standard maintenance from 7:30 p.m. ET to 10:30 p.m. ET on Thursday, April 18, 2024. Prior authorization requests (PARs) with a due date of April 18, 2024 will be extended to April 19, 2024.

Subject Number 046-597 Temporary Suspension of Dr. Dhanraj Soogree's Authorization to Treat Injured Workers Effective August 5, 2013

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 210443-8W

August 5, 2013

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Dhanraj Soogree's authorization to treat injured workers within the New York State workers' compensation system effective August 5, 2013. Dr. Soogree's last known business address is 144 West 4th Street, Oswego, New York 13126.

The Chair's designee's investigation revealed that the Department of Health, Bureau of Professional Medical Conduct (BPMC) has issued BPMC Order # 13-75, wherein, Dr. Soogree did not contest the charge of negligence on more than one occasion and admitted to a charge of failing to maintain adequate patient records. His medical license has been limited to preclude all patient contact and the practice of medicine clinical or otherwise. He also may not use his medical license as a basis for practicing any other profession licensed or regulated by the New York State Board of Regents, Department of Health of Department of State. Therefore, the Chair believes that Dr. Soogree may be guilty of misconduct.

Dr. Soogree is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Soogree for services rendered prior to August 5, 2013, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Soogree for services rendered prior to August 5, 2013, should not be denied due to the suspension of his/her authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director's Office at 1 (800) 781-2362.

Robert E. Beloten
Chair